Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | CRHBP | P24387 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenaceturic Acid SCHEMBL14126285 | 1.00 | ATM (0.62) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL11288698 | 0.96 | ATM (0.59) | ATMKMT2AMEN1HDAC8HDAC6 | |
| Phenaceturic Acid SCHEMBL28124919 | 0.93 | ATM (0.56) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL1454495 | 0.85 | MEN1 (0.63) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL7769258 | 0.84 | KMT2A (0.57) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL21398985 | 0.84 | KMT2A (0.57) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL5102819 | 0.84 | KMT2A (0.57) | ATMKMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL935646 | 0.84 | CA2 (0.61) | ATMALDH1A1LMNARAB9AL3MBTL1 | |
| SCHEMBL7769256 | 0.84 | KMT2A (0.57) | ATMKMT2AMEN1HDAC8HDAC6 | |
| Phenaceturic Acid SCHEMBL20912457 | 0.84 | SLC7A5 (0.65) | ATMKMT2AMEN1HPGDCRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2025133394-A1 | METABOLIC FINGERPRINTING OF SALIVA SAMPLES USING NMR | MAVEN HEALTH GMBH (CH) | 2025-06-26 | — | — | WO | claimed |
| US-12292445-B2 | Methods of selecting subjects for treatment with metabolomic modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-06 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119125369-A | Method for extracting and separating 5 nonsteroidal accompanying components in natural source conjugated estrogens | 特丰制药有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119044503-A | Phenylacetylglycine as biomarker for microglial activation and application thereof | 中国农业大学 | 2024-11-29 | — | — | CN | claimed |
| WO-2024243289-A2 | GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-11-28 | — | — | WO | claimed |
| WO-2008097491-A2 | BIOMARKERS OF IONIZING RADIATION RESPONSE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-08-14 | — | — | WO | claimed |
| US-20080187952-A1 | Biomarkers of Ionizing Radiation Response | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-08-07 | — | — | US | claimed |
| US-7399638-B2 | Prediction method for lipidosis | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-07-15 | — | — | US | claimed |
| US-20070166829-A1 | Prediction method for lipidosis | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-07-19 | — | — | US | claimed |
| EP-1710585-A1 | METHOD OF PREDICTING ABNORMALITY OF LIPID METABOLISM | Takeda Pharmaceutical Company Limited (JP) | 2006-10-11 | — | — | EP | claimed |
| EP-1047391-A4 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2005-01-19 | — | — | EP | claimed |
| US-6238655-B1 | USEFUL IN THE FORMULATION OF DEODORANTS, ANTIPERSPIRANTS, BODY SPRAYS, AND OTHER SKIN TREATMENT COMPOSITIONS. | THE GILLETTE COMPANY | 2001-05-29 | — | — | US | claimed |
| EP-1047391-A1 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-02 | — | — | EP | claimed |
| WO-1999030679-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | IAPP, GPR119, FAHD1 | ATM 1093/4885KMT2A 2945/4885MEN1 361/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | ATM 3069/4885KMT2A 650/4885MEN1 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.